Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $183,407 - $239,418
4,393 New
4,393 $225,000
Q1 2022

May 05, 2022

BUY
$45.75 - $56.69 $194,346 - $240,819
4,248 New
4,248 $220,000
Q1 2021

May 13, 2021

SELL
$33.49 - $37.77 $507,072 - $571,875
-15,141 Closed
0 $0
Q4 2020

Feb 04, 2021

BUY
$33.47 - $42.56 $114,567 - $145,682
3,423 Added 29.21%
15,141 $557,000
Q3 2020

Nov 05, 2020

BUY
$31.75 - $37.25 $59,086 - $69,322
1,861 Added 18.88%
11,718 $432,000
Q2 2020

Jul 30, 2020

SELL
$30.12 - $36.54 $9,216 - $11,181
-306 Reduced 3.01%
9,857 $330,000
Q1 2020

May 08, 2020

SELL
$27.03 - $38.62 $366,580 - $523,764
-13,562 Reduced 57.16%
10,163 $332,000
Q4 2019

Feb 07, 2020

BUY
$32.92 - $37.36 $184,648 - $209,552
5,609 Added 30.96%
23,725 $930,000
Q3 2019

Nov 07, 2019

SELL
$32.49 - $42.13 $109,393 - $141,851
-3,367 Reduced 15.67%
18,116 $653,000
Q2 2019

Jul 25, 2019

BUY
$36.98 - $41.52 $18,674 - $20,967
505 Added 2.41%
21,483 $931,000
Q1 2019

May 10, 2019

BUY
$37.5 - $41.2 $105,262 - $115,648
2,807 Added 15.45%
20,978 $891,000
Q4 2018

Jan 31, 2019

SELL
$38.47 - $43.86 $4,424 - $5,043
-115 Reduced 0.63%
18,171 $793,000
Q3 2018

Nov 09, 2018

SELL
$34.47 - $41.81 $24,852 - $30,145
-721 Reduced 3.79%
18,286 $806,000
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $98 - $105
3 Added 0.02%
19,007 $700,000
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $6,669 - $7,737
-209 Reduced 1.09%
19,004 $674,000
Q4 2017

Feb 13, 2018

BUY
$33.26 - $35.29 $65,222 - $69,203
1,961 Added 11.37%
19,213 $696,000
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $155 - $170
5 Added 0.03%
17,252 $616,000
Q2 2017

Aug 16, 2017

BUY
N/A
17,247
17,247 $579,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Hcr Wealth Advisors Portfolio

Follow Hcr Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hcr Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Hcr Wealth Advisors with notifications on news.